 | • レポートコード：QYR2104Z4621 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ピロカルピンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、点眼薬）、用途別市場規模（眼科、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ピロカルピンの市場動向 ・企業の競争状況、市場シェア ・ピロカルピンの種類別市場規模（注射、点眼薬） ・ピロカルピンの用途別市場規模（眼科、病院、その他） ・ピロカルピンの北米市場規模2016-2027（アメリカ、カナダ） ・ピロカルピンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ピロカルピンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ピロカルピンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ピロカルピンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AUROBINDO PHARMA LTD、Kissei、NOVARTIS、AKORN INC、SOMERSET THERAPS LLC、IMPAX LABS、Santen Oy、King York、Sandoz、Novartis AG、Rebel Distributors Corp.） ・結論 |
Pilocarpine is a cholinergic parasympathomimetic agent. It increase secretion by the exocrine glands, and produces contraction of the iris sphincter muscle and ciliary muscle (when given topically to the eyes) by mainly stimulating muscarinic receptors.
Market Analysis and Insights: Global Pilocarpine Market
The global Pilocarpine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pilocarpine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pilocarpine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pilocarpine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pilocarpine market.
Global Pilocarpine Scope and Market Size
Pilocarpine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pilocarpine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Eye Drop
Segment by Application
Eye Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AUROBINDO PHARMA LTD
Kissei
NOVARTIS
AKORN INC
SOMERSET THERAPS LLC
IMPAX LABS
Santen Oy
King York
Sandoz
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pilocarpine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Eye Drop
1.3 Market by Application
1.3.1 Global Pilocarpine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Eye Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pilocarpine Market Perspective (2016-2027)
2.2 Pilocarpine Growth Trends by Regions
2.2.1 Pilocarpine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pilocarpine Historic Market Share by Regions (2016-2021)
2.2.3 Pilocarpine Forecasted Market Size by Regions (2022-2027)
2.3 Pilocarpine Industry Dynamic
2.3.1 Pilocarpine Market Trends
2.3.2 Pilocarpine Market Drivers
2.3.3 Pilocarpine Market Challenges
2.3.4 Pilocarpine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pilocarpine Players by Revenue
3.1.1 Global Top Pilocarpine Players by Revenue (2016-2021)
3.1.2 Global Pilocarpine Revenue Market Share by Players (2016-2021)
3.2 Global Pilocarpine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pilocarpine Revenue
3.4 Global Pilocarpine Market Concentration Ratio
3.4.1 Global Pilocarpine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pilocarpine Revenue in 2020
3.5 Pilocarpine Key Players Head office and Area Served
3.6 Key Players Pilocarpine Product Solution and Service
3.7 Date of Enter into Pilocarpine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pilocarpine Breakdown Data by Type
4.1 Global Pilocarpine Historic Market Size by Type (2016-2021)
4.2 Global Pilocarpine Forecasted Market Size by Type (2022-2027)
5 Pilocarpine Breakdown Data by Application
5.1 Global Pilocarpine Historic Market Size by Application (2016-2021)
5.2 Global Pilocarpine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pilocarpine Market Size (2016-2027)
6.2 North America Pilocarpine Market Size by Type
6.2.1 North America Pilocarpine Market Size by Type (2016-2021)
6.2.2 North America Pilocarpine Market Size by Type (2022-2027)
6.2.3 North America Pilocarpine Market Size by Type (2016-2027)
6.3 North America Pilocarpine Market Size by Application
6.3.1 North America Pilocarpine Market Size by Application (2016-2021)
6.3.2 North America Pilocarpine Market Size by Application (2022-2027)
6.3.3 North America Pilocarpine Market Size by Application (2016-2027)
6.4 North America Pilocarpine Market Size by Country
6.4.1 North America Pilocarpine Market Size by Country (2016-2021)
6.4.2 North America Pilocarpine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pilocarpine Market Size (2016-2027)
7.2 Europe Pilocarpine Market Size by Type
7.2.1 Europe Pilocarpine Market Size by Type (2016-2021)
7.2.2 Europe Pilocarpine Market Size by Type (2022-2027)
7.2.3 Europe Pilocarpine Market Size by Type (2016-2027)
7.3 Europe Pilocarpine Market Size by Application
7.3.1 Europe Pilocarpine Market Size by Application (2016-2021)
7.3.2 Europe Pilocarpine Market Size by Application (2022-2027)
7.3.3 Europe Pilocarpine Market Size by Application (2016-2027)
7.4 Europe Pilocarpine Market Size by Country
7.4.1 Europe Pilocarpine Market Size by Country (2016-2021)
7.4.2 Europe Pilocarpine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pilocarpine Market Size (2016-2027)
8.2 Asia-Pacific Pilocarpine Market Size by Type
8.2.1 Asia-Pacific Pilocarpine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pilocarpine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pilocarpine Market Size by Type (2016-2027)
8.3 Asia-Pacific Pilocarpine Market Size by Application
8.3.1 Asia-Pacific Pilocarpine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pilocarpine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pilocarpine Market Size by Application (2016-2027)
8.4 Asia-Pacific Pilocarpine Market Size by Region
8.4.1 Asia-Pacific Pilocarpine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pilocarpine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pilocarpine Market Size (2016-2027)
9.2 Latin America Pilocarpine Market Size by Type
9.2.1 Latin America Pilocarpine Market Size by Type (2016-2021)
9.2.2 Latin America Pilocarpine Market Size by Type (2022-2027)
9.2.3 Latin America Pilocarpine Market Size by Type (2016-2027)
9.3 Latin America Pilocarpine Market Size by Application
9.3.1 Latin America Pilocarpine Market Size by Application (2016-2021)
9.3.2 Latin America Pilocarpine Market Size by Application (2022-2027)
9.3.3 Latin America Pilocarpine Market Size by Application (2016-2027)
9.4 Latin America Pilocarpine Market Size by Country
9.4.1 Latin America Pilocarpine Market Size by Country (2016-2021)
9.4.2 Latin America Pilocarpine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pilocarpine Market Size (2016-2027)
10.2 Middle East & Africa Pilocarpine Market Size by Type
10.2.1 Middle East & Africa Pilocarpine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pilocarpine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pilocarpine Market Size by Type (2016-2027)
10.3 Middle East & Africa Pilocarpine Market Size by Application
10.3.1 Middle East & Africa Pilocarpine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pilocarpine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pilocarpine Market Size by Application (2016-2027)
10.4 Middle East & Africa Pilocarpine Market Size by Country
10.4.1 Middle East & Africa Pilocarpine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pilocarpine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AUROBINDO PHARMA LTD
11.1.1 AUROBINDO PHARMA LTD Company Details
11.1.2 AUROBINDO PHARMA LTD Business Overview
11.1.3 AUROBINDO PHARMA LTD Pilocarpine Introduction
11.1.4 AUROBINDO PHARMA LTD Revenue in Pilocarpine Business (2016-2021)
11.1.5 AUROBINDO PHARMA LTD Recent Development
11.2 Kissei
11.2.1 Kissei Company Details
11.2.2 Kissei Business Overview
11.2.3 Kissei Pilocarpine Introduction
11.2.4 Kissei Revenue in Pilocarpine Business (2016-2021)
11.2.5 Kissei Recent Development
11.3 NOVARTIS
11.3.1 NOVARTIS Company Details
11.3.2 NOVARTIS Business Overview
11.3.3 NOVARTIS Pilocarpine Introduction
11.3.4 NOVARTIS Revenue in Pilocarpine Business (2016-2021)
11.3.5 NOVARTIS Recent Development
11.4 AKORN INC
11.4.1 AKORN INC Company Details
11.4.2 AKORN INC Business Overview
11.4.3 AKORN INC Pilocarpine Introduction
11.4.4 AKORN INC Revenue in Pilocarpine Business (2016-2021)
11.4.5 AKORN INC Recent Development
11.5 SOMERSET THERAPS LLC
11.5.1 SOMERSET THERAPS LLC Company Details
11.5.2 SOMERSET THERAPS LLC Business Overview
11.5.3 SOMERSET THERAPS LLC Pilocarpine Introduction
11.5.4 SOMERSET THERAPS LLC Revenue in Pilocarpine Business (2016-2021)
11.5.5 SOMERSET THERAPS LLC Recent Development
11.6 IMPAX LABS
11.6.1 IMPAX LABS Company Details
11.6.2 IMPAX LABS Business Overview
11.6.3 IMPAX LABS Pilocarpine Introduction
11.6.4 IMPAX LABS Revenue in Pilocarpine Business (2016-2021)
11.6.5 IMPAX LABS Recent Development
11.7 Santen Oy
11.7.1 Santen Oy Company Details
11.7.2 Santen Oy Business Overview
11.7.3 Santen Oy Pilocarpine Introduction
11.7.4 Santen Oy Revenue in Pilocarpine Business (2016-2021)
11.7.5 Santen Oy Recent Development
11.8 King York
11.8.1 King York Company Details
11.8.2 King York Business Overview
11.8.3 King York Pilocarpine Introduction
11.8.4 King York Revenue in Pilocarpine Business (2016-2021)
11.8.5 King York Recent Development
11.9 Sandoz
11.9.1 Sandoz Company Details
11.9.2 Sandoz Business Overview
11.9.3 Sandoz Pilocarpine Introduction
11.9.4 Sandoz Revenue in Pilocarpine Business (2016-2021)
11.9.5 Sandoz Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Pilocarpine Introduction
11.10.4 Novartis AG Revenue in Pilocarpine Business (2016-2021)
11.10.5 Novartis AG Recent Development
11.11 Rebel Distributors Corp.
11.11.1 Rebel Distributors Corp. Company Details
11.11.2 Rebel Distributors Corp. Business Overview
11.11.3 Rebel Distributors Corp. Pilocarpine Introduction
11.11.4 Rebel Distributors Corp. Revenue in Pilocarpine Business (2016-2021)
11.11.5 Rebel Distributors Corp. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pilocarpine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Eye Drop
Table 4. Global Pilocarpine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pilocarpine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pilocarpine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pilocarpine Market Share by Regions (2016-2021)
Table 8. Global Pilocarpine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pilocarpine Market Share by Regions (2022-2027)
Table 10. Pilocarpine Market Trends
Table 11. Pilocarpine Market Drivers
Table 12. Pilocarpine Market Challenges
Table 13. Pilocarpine Market Restraints
Table 14. Global Pilocarpine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pilocarpine Market Share by Players (2016-2021)
Table 16. Global Top Pilocarpine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pilocarpine as of 2020)
Table 17. Ranking of Global Top Pilocarpine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pilocarpine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pilocarpine Product Solution and Service
Table 21. Date of Enter into Pilocarpine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pilocarpine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pilocarpine Revenue Market Share by Type (2016-2021)
Table 25. Global Pilocarpine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pilocarpine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pilocarpine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pilocarpine Revenue Market Share by Application (2016-2021)
Table 29. Global Pilocarpine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pilocarpine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pilocarpine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pilocarpine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pilocarpine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pilocarpine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pilocarpine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pilocarpine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pilocarpine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pilocarpine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pilocarpine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pilocarpine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pilocarpine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pilocarpine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pilocarpine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pilocarpine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pilocarpine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pilocarpine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pilocarpine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pilocarpine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pilocarpine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pilocarpine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pilocarpine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pilocarpine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pilocarpine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pilocarpine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pilocarpine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pilocarpine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pilocarpine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pilocarpine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pilocarpine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pilocarpine Market Size by Country (2022-2027) & (US$ Million)
Table 61. AUROBINDO PHARMA LTD Company Details
Table 62. AUROBINDO PHARMA LTD Business Overview
Table 63. AUROBINDO PHARMA LTD Pilocarpine Product
Table 64. AUROBINDO PHARMA LTD Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 65. AUROBINDO PHARMA LTD Recent Development
Table 66. Kissei Company Details
Table 67. Kissei Business Overview
Table 68. Kissei Pilocarpine Product
Table 69. Kissei Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 70. Kissei Recent Development
Table 71. NOVARTIS Company Details
Table 72. NOVARTIS Business Overview
Table 73. NOVARTIS Pilocarpine Product
Table 74. NOVARTIS Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 75. NOVARTIS Recent Development
Table 76. AKORN INC Company Details
Table 77. AKORN INC Business Overview
Table 78. AKORN INC Pilocarpine Product
Table 79. AKORN INC Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 80. AKORN INC Recent Development
Table 81. SOMERSET THERAPS LLC Company Details
Table 82. SOMERSET THERAPS LLC Business Overview
Table 83. SOMERSET THERAPS LLC Pilocarpine Product
Table 84. SOMERSET THERAPS LLC Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 85. SOMERSET THERAPS LLC Recent Development
Table 86. IMPAX LABS Company Details
Table 87. IMPAX LABS Business Overview
Table 88. IMPAX LABS Pilocarpine Product
Table 89. IMPAX LABS Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 90. IMPAX LABS Recent Development
Table 91. Santen Oy Company Details
Table 92. Santen Oy Business Overview
Table 93. Santen Oy Pilocarpine Product
Table 94. Santen Oy Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 95. Santen Oy Recent Development
Table 96. King York Company Details
Table 97. King York Business Overview
Table 98. King York Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 99. King York Recent Development
Table 100. Sandoz Company Details
Table 101. Sandoz Business Overview
Table 102. Sandoz Pilocarpine Product
Table 103. Sandoz Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 104. Sandoz Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Pilocarpine Product
Table 108. Novartis AG Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. Rebel Distributors Corp. Company Details
Table 111. Rebel Distributors Corp. Business Overview
Table 112. Rebel Distributors Corp. Pilocarpine Product
Table 113. Rebel Distributors Corp. Revenue in Pilocarpine Business (2016-2021) & (US$ Million)
Table 114. Rebel Distributors Corp. Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pilocarpine Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Eye Drop Features
Figure 4. Global Pilocarpine Market Share by Application: 2020 VS 2027
Figure 5. Eye Clinic Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. Pilocarpine Report Years Considered
Figure 9. Global Pilocarpine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pilocarpine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pilocarpine Market Share by Regions: 2020 VS 2027
Figure 12. Global Pilocarpine Market Share by Regions (2022-2027)
Figure 13. Global Pilocarpine Market Share by Players in 2020
Figure 14. Global Top Pilocarpine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pilocarpine as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pilocarpine Revenue in 2020
Figure 16. Global Pilocarpine Revenue Market Share by Type (2016-2021)
Figure 17. Global Pilocarpine Revenue Market Share by Type (2022-2027)
Figure 18. North America Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pilocarpine Market Share by Type (2016-2027)
Figure 20. North America Pilocarpine Market Share by Application (2016-2027)
Figure 21. North America Pilocarpine Market Share by Country (2016-2027)
Figure 22. United States Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pilocarpine Market Share by Type (2016-2027)
Figure 26. Europe Pilocarpine Market Share by Application (2016-2027)
Figure 27. Europe Pilocarpine Market Share by Country (2016-2027)
Figure 28. Germany Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pilocarpine Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pilocarpine Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pilocarpine Market Share by Region (2016-2027)
Figure 38. China Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pilocarpine Market Share by Type (2016-2027)
Figure 46. Latin America Pilocarpine Market Share by Application (2016-2027)
Figure 47. Latin America Pilocarpine Market Share by Country (2016-2027)
Figure 48. Mexico Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pilocarpine Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pilocarpine Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pilocarpine Market Share by Country (2016-2027)
Figure 54. Turkey Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pilocarpine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AUROBINDO PHARMA LTD Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 58. Kissei Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 59. NOVARTIS Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 60. AKORN INC Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 61. SOMERSET THERAPS LLC Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 62. IMPAX LABS Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 63. Santen Oy Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 64. King York Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 65. Sandoz Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 67. Rebel Distributors Corp. Revenue Growth Rate in Pilocarpine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のトラックホイールエンドメンテナンスマーク市場規模・現状・予測（2021年-2027年） SIMO power management IC is based on single-inductor-multiple-output (SIMO) architecture. It incorporates single inductor as an energy storage element for multiple DC outputs. Since fewer inductors are used, power supply size is reduced to 50% and efficiency is also improved. Thus, SIMO PMIC deliver…- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …
- 世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …